Table II. Drugs against breast cancer. The first column contains FDA-approved drugs against breast cancer (71), the second column contains the compact list after removing duplicates (31 drugs), and the third column contains drugs that were applied to patients in the TCGA panel (38). Twentythree out of 38 drugs applied to TCGA-patients were FDA-approved drugs. The drugs marked in bold are found both in the second and third column.